| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 45,200 | 33,396 | 88,845 | 195,406 | | Cost of Revenue | 33,360 | 29,169 | 43,882 | 77,972 | | | Gross Profit | 11,840 | 4,227 | 44,963 | 117,434 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 9,627 | 14,784 | 12,094 | 10,555 | | Non Recurring |
-
|
-
| (120) |
-
| | Others | 32,277 | 33,844 | 34,344 | 32,694 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (30,064) | (44,401) | (1,355) | 74,185 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (13,086) | 12 | 20 | 94 | | Earnings Before Interest And Taxes | (29,856) | (44,389) | (1,335) | 74,279 | | Interest Expense | 9,221 | 9,420 | 8,383 | 8,989 | | Income Before Tax | (39,077) | (53,809) | (9,718) | 65,290 | | Income Tax Expense | (14,601) | (20,617) | (4,015) | 24,237 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (24,476) | (33,192) | (5,703) | 41,053 | | | Non-recurring Events | | Discontinued Operations |
-
| 113 |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (24,476) | (33,079) | (5,703) | 41,053 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($24,476) | ($33,079) | ($5,703) | $41,053 |
|
0.31% Nasdaq 
0.05%
Income Statement
